Posted on

Agtech Announces the Termination of the Planned Acquisition of Noomeds LLC

Agtech Announces the Termination of the Planned Acquisition of Noomeds LLC

Newport Beach, CALIFORNIA, March 10, 2022 (GLOBE NEWSWIRE) — Agtech Global International, Inc. (Agtech) (OTC Pink: AGGL) announces that due to unexpected delays in Agtech’s funding of the purchase, the final consummation of the Memorandum of Understanding between Dr. Malcolm A. Leissring and the planned acquisition of his company NooMeds, LLC. will not proceed and is hereby terminated.

As a result of this change, Dr. Leissring will not continue in the consulting role as Chief Scientific Officer and Agtech will not have any future involvement with the AD Foundation.

Agtech is publicly traded on the OTC Markets (OTC Pink: AGGL). Headquartered in Newport Beach, California, Agtech is entering the rapidly developing markets for premium CBD consumer products through its recent acquisition of Galexxy Corporation and its joint venture with City Farm Industries. Agtech’s “soil-to-sale” business strategy is keenly focused on controlling the supply chain and maximizing profits.

Agtech Global International, Inc.Ross Lyndon-JamesE: ross@galexxy.com M: (949) 456 3972

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements” (collectively, “statements”). All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release.

www.agtech.net

Posted on

Agtech Appoints Leading Harvard Trained Medical Expert as Chief Science Officer

Agtech Appoints Leading Harvard Trained Medical Expert as Chief Science Officer

CALIFORNIA, Newport Beach, Dec. 09, 2021 (GLOBE NEWSWIRE) — Agtech Global International, Inc. (Agtech) (name change to Galexxy Holdings Inc. in process) (OTC Pink: AGGL) is pleased to announce the appointment of Dr. Malcolm A. Leissring as its Chief Science Officer (CSO) effective January 1, 2022. This appointment follows Agtech’s recent agreement to acquire NooMeds, LLC., a company formed by Dr. Leissring to market A.L.Z. Defense™, a scientifically tested dietary supplement shown to prevent memory problems in laboratory models of Alzheimer’s disease.

Dr. Leissring is an award-winning neuroscientist who is internationally recognized for his work on the molecular pathogenesis of Alzheimer’s disease and diabetes, with an emphasis on drug discovery and development.  He conducted his postdoctoral training at Harvard Medical School in the laboratory of Dennis J. Selkoe, M.D., one of the world’s leading researchers in Alzheimer’s disease.  

His research has been funded by grants from the National Institutes of Health (NIH) and numerous private foundations. For his pioneering work on Alzheimer’s disease and diabetes, Dr. Leissring has received awards from many prestigious organizations, such as the Alzheimer’s Association, the Ellison Medical Foundation, the American Federation for Aging Research and the American Diabetes Association.  Dr. Leissring was recently awarded a $3 million grant from the NIH’s National Institute on Aging to continue his research on Alzheimer’s disease at the University of California, Irvine.  

In his role as CSO of Agtech/Galexxy, Dr. Leissring will help direct the research and drug development program for the novel compounding of psilocybin and cannabidiol (CBD) into proprietary formulations. This program is being conducted by KRTL Biotech, Inc. in South Korea.

Dr. Leissring added, “I’m excited by this KRTL drug development opportunity to help formally evaluate the therapeutic potential of highly promising compounds that have been in use for millennia, but have been off limits to investigators until only recently.” 

Agtech is publicly traded on the OTC Markets (OTC Pink: AGGL). Headquartered in Newport Beach, California, Agtech is entering the rapidly developing markets for premium CBD consumer products through its recent acquisition of Galexxy Corporation and its joint venture with City Farm Industries. Agtech’s “soil-to-sale” business strategy is keenly focused on controlling the supply chain and maximizing profits.

Agtech Global International, Inc.Ross Lyndon-JamesE: ross@galexxy.com M: (949) 456 3972

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements” (collectively, “statements”). All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release.

https://twitter.com/AgtechGlobal                                   https://www.krtlbiotech.comhttp://galexxyholdings.com.dream.website

Attachment

Primary Logo
$AGGL – Agtech Appoints Leading Harvard Trained Medical Expert as Chief Science Officer

Malcolm A. Leissring, Ph.D.

Galexxy Holdings Inc.

Posted on

Agtech to Launch GENUS™ App – A Crypto Enabled Consumer App for Hemp CBD Markets

Agtech to Launch GENUS™ App – A Crypto Enabled Consumer App for Hemp CBD Markets

CALIFORNIA, Newport Beach, Nov. 22, 2021 (GLOBE NEWSWIRE) — Agtech Global International Inc. (OTC Pink: AGGL) (Agtech) (name change to Galexxy Holdings Inc. in process) is preparing to release its market disrupting Genus™ App; which combines an innovative range of features including digital token capabilities and is targeted to disrupt Hemp CBD and future Cannabis markets.

The GENUS™ App is a free, virtual “Business in a Box” App for consumers. At its core, the App will not only enable rapid access for discounted products and income generation opportunities, but also offer a host of health and wellness information to users and provide services in line with the Company’s recently trademarked Healthfullness™ wellness category.

Agtech’s strategy is to achieve early market penetration and rapid growth by marketing its range of online GENUS CBD products direct to consumers, using its patent pending Virtual Retail Marketing System™ (VRMS) and its GENUS App, which are unique hybrid retailing approaches. VRMS combines the physical attributes of the “Brick & Mortar” customer experience with the ease and convenience of online digital shopping.  The future potential deployment of VRMS units in thousands of businesses and retail outlets and the GENUS App on hundreds of thousands of Members’ mobile devices is expected to appeal to millions of discerning consumers.

Agtech is a publicly traded company on OTC Markets Pink (OTC Pink: AGGL). Based in Newport Beach, California, Agtech recently restructured its agricultural supplies business to enter the rapidly developing markets for premium CBD consumer products. Its “soil to sale” business strategy is keenly focused on the important synergy of health and wealth. Galexxy Corporation is also based in Newport Beach and was recently acquired by AGGL for its IP and its aggressive plans to enter the CBD consumer products market.

The GENUS App will be free to download offering the following benefits:

  • Purchasing products at discounted prices and earning GENUS Gold tokens at no cost;
  • Sharing the APP with others and earning referral fees and GENUS Gold tokens;
  • Developing a sustainable income by sharing the App and GENUS products with others;
  • Accessing new issues of tradable GENUS Gold tokens.

Agtech is developing its new Healthfullness market by:

  • Launching proprietary innovations in upward trending consumer markets.
  • Using highly scalable leading edge, patented technologies and products.
  • Engaging a high-powered social media group with proven publicity strategies.
  • Providing attractive personal financial rewards for its customers and members.

Agtech’s Business Plan Includes:

  • Production capacity of proprietary formulations for popular CBD consumer products.
  • Healthfullness related products and services to complement its CBD product range.
  • Large-scale deployment of a unique, patent pending Virtual Retail Marketing System.
  • A fully encrypted, advanced Blockchain Operating System to enable rapid scalability.
  • A Blockchain Partner with all necessary technical and support capabilities.
  • A free to download patented GENUS App loaded with cutting-edge features and uses.
  • A free “Business in a Box” mobile operating system with inbuilt financial rewards.
  • A free Crypto bonus reward feature with redemption capabilities.
  • A proven Social Media marketing group with high-profile celebrities and Crypto leaders.

For further information:

Agtech Global International Inc.Ross Lyndon-JamesE: ross@galexxy.com M: (949) 456 3972

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements” (collectively, “statements”). All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release.

https://twitter.com/AgtechGlobal

http://galexxyholdings.com.dream.website/

Posted on

Researching ADHD treatments in Korea

Agtech and KRTL Biotech Join Forces to Develop and Distribute Unique CBD and Psilocybin Products

These companies are joining forces to develop unique treatments for a range of debilitating conditions.

Agtech Global International Inc. (AGGL) and  KRTL Biotech Inc. are partnering to develop CBD and psilocybin-based medicines to treat conditions like ADHD, pain from cancer, autism, PTSD,  depression, and addiction.

The agreement will leverage KRTL’s team of researchers in the US and Korea, where they have already received the Korean equivalent of FDA approval to study the compounds.

Several other companies are supporting the research project including Here To Serve Holding Corp. (HTSC) and Pervasip Corp. (PVSP).

PDF of article